A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line

Yuma Yamada, Mai Tabata, Yukari Yasuzaki, Masatoshi Nomura, Atsushi Shibata, Yuta Ibayashi, Yosuke Taniguchi, Shigeki Sasaki, Hideyoshi Harashima

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Pancreatic β cells secrete insulin in response to glucose levels and thus are involved in controlling blood glucose levels. A line of pancreatic β cells "MIN6" has been used in studies related to the function of β cells and diabetes therapy. Regulating gene expression in MIN6 cells could accelerate these studies, but an efficient method for the transfection of nucleic acids targeted to MIN6 cells is required. We report here on a liposome-based carrier targeted to pancreatic β cells (Multifunctional envelope-type nano device for pancreatic β cells, β-MEND). We identified a lipid composition for use in preparing the β-MEND, which permits the particles to be efficiently internalized into MIN6, as evidenced by flow cytometry analyses. Intracellular observation by confocal laser scanning microscopy showed that the β-MEND efficiently delivered the oligo nucleic acids to the cytosol of MIN6 cells. Moreover, using a β-MEND encapsulating a 2'-O-Methyl RNA complementary to a microRNA that suppresses insulin secretion, the knockdown of the targeted microRNA and an up-regulation of insulin secretion were observed in MIN6. Thus, the β-MEND holds promise as an efficient system for delivering nucleic acids targeted to MIN6 and can contribute to research and therapy aimed at diabetes.

Original languageEnglish
Pages (from-to)6430-6438
Number of pages9
JournalBiomaterials
Volume35
Issue number24
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Insulin
Nucleic acids
Insulin-Secreting Cells
Nucleic Acids
Cells
Medical problems
Cell Line
Glucose
MicroRNAs
Flow cytometry
Liposomes
Gene expression
Lipids
Microscopic examination
Blood
Complementary RNA
Glucagon-Secreting Cells
Scanning
Lasers
Blood Glucose

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Yamada, Y., Tabata, M., Yasuzaki, Y., Nomura, M., Shibata, A., Ibayashi, Y., ... Harashima, H. (2014). A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials, 35(24), 6430-6438. https://doi.org/10.1016/j.biomaterials.2014.04.017

A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. / Yamada, Yuma; Tabata, Mai; Yasuzaki, Yukari; Nomura, Masatoshi; Shibata, Atsushi; Ibayashi, Yuta; Taniguchi, Yosuke; Sasaki, Shigeki; Harashima, Hideyoshi.

In: Biomaterials, Vol. 35, No. 24, 01.01.2014, p. 6430-6438.

Research output: Contribution to journalArticle

Yamada, Y, Tabata, M, Yasuzaki, Y, Nomura, M, Shibata, A, Ibayashi, Y, Taniguchi, Y, Sasaki, S & Harashima, H 2014, 'A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line', Biomaterials, vol. 35, no. 24, pp. 6430-6438. https://doi.org/10.1016/j.biomaterials.2014.04.017
Yamada Y, Tabata M, Yasuzaki Y, Nomura M, Shibata A, Ibayashi Y et al. A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials. 2014 Jan 1;35(24):6430-6438. https://doi.org/10.1016/j.biomaterials.2014.04.017
Yamada, Yuma ; Tabata, Mai ; Yasuzaki, Yukari ; Nomura, Masatoshi ; Shibata, Atsushi ; Ibayashi, Yuta ; Taniguchi, Yosuke ; Sasaki, Shigeki ; Harashima, Hideyoshi. / A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. In: Biomaterials. 2014 ; Vol. 35, No. 24. pp. 6430-6438.
@article{fc74ab70308c4ee7bcf0a1719f096785,
title = "A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line",
abstract = "Pancreatic β cells secrete insulin in response to glucose levels and thus are involved in controlling blood glucose levels. A line of pancreatic β cells {"}MIN6{"} has been used in studies related to the function of β cells and diabetes therapy. Regulating gene expression in MIN6 cells could accelerate these studies, but an efficient method for the transfection of nucleic acids targeted to MIN6 cells is required. We report here on a liposome-based carrier targeted to pancreatic β cells (Multifunctional envelope-type nano device for pancreatic β cells, β-MEND). We identified a lipid composition for use in preparing the β-MEND, which permits the particles to be efficiently internalized into MIN6, as evidenced by flow cytometry analyses. Intracellular observation by confocal laser scanning microscopy showed that the β-MEND efficiently delivered the oligo nucleic acids to the cytosol of MIN6 cells. Moreover, using a β-MEND encapsulating a 2'-O-Methyl RNA complementary to a microRNA that suppresses insulin secretion, the knockdown of the targeted microRNA and an up-regulation of insulin secretion were observed in MIN6. Thus, the β-MEND holds promise as an efficient system for delivering nucleic acids targeted to MIN6 and can contribute to research and therapy aimed at diabetes.",
author = "Yuma Yamada and Mai Tabata and Yukari Yasuzaki and Masatoshi Nomura and Atsushi Shibata and Yuta Ibayashi and Yosuke Taniguchi and Shigeki Sasaki and Hideyoshi Harashima",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2014.04.017",
language = "English",
volume = "35",
pages = "6430--6438",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "24",

}

TY - JOUR

T1 - A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line

AU - Yamada, Yuma

AU - Tabata, Mai

AU - Yasuzaki, Yukari

AU - Nomura, Masatoshi

AU - Shibata, Atsushi

AU - Ibayashi, Yuta

AU - Taniguchi, Yosuke

AU - Sasaki, Shigeki

AU - Harashima, Hideyoshi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Pancreatic β cells secrete insulin in response to glucose levels and thus are involved in controlling blood glucose levels. A line of pancreatic β cells "MIN6" has been used in studies related to the function of β cells and diabetes therapy. Regulating gene expression in MIN6 cells could accelerate these studies, but an efficient method for the transfection of nucleic acids targeted to MIN6 cells is required. We report here on a liposome-based carrier targeted to pancreatic β cells (Multifunctional envelope-type nano device for pancreatic β cells, β-MEND). We identified a lipid composition for use in preparing the β-MEND, which permits the particles to be efficiently internalized into MIN6, as evidenced by flow cytometry analyses. Intracellular observation by confocal laser scanning microscopy showed that the β-MEND efficiently delivered the oligo nucleic acids to the cytosol of MIN6 cells. Moreover, using a β-MEND encapsulating a 2'-O-Methyl RNA complementary to a microRNA that suppresses insulin secretion, the knockdown of the targeted microRNA and an up-regulation of insulin secretion were observed in MIN6. Thus, the β-MEND holds promise as an efficient system for delivering nucleic acids targeted to MIN6 and can contribute to research and therapy aimed at diabetes.

AB - Pancreatic β cells secrete insulin in response to glucose levels and thus are involved in controlling blood glucose levels. A line of pancreatic β cells "MIN6" has been used in studies related to the function of β cells and diabetes therapy. Regulating gene expression in MIN6 cells could accelerate these studies, but an efficient method for the transfection of nucleic acids targeted to MIN6 cells is required. We report here on a liposome-based carrier targeted to pancreatic β cells (Multifunctional envelope-type nano device for pancreatic β cells, β-MEND). We identified a lipid composition for use in preparing the β-MEND, which permits the particles to be efficiently internalized into MIN6, as evidenced by flow cytometry analyses. Intracellular observation by confocal laser scanning microscopy showed that the β-MEND efficiently delivered the oligo nucleic acids to the cytosol of MIN6 cells. Moreover, using a β-MEND encapsulating a 2'-O-Methyl RNA complementary to a microRNA that suppresses insulin secretion, the knockdown of the targeted microRNA and an up-regulation of insulin secretion were observed in MIN6. Thus, the β-MEND holds promise as an efficient system for delivering nucleic acids targeted to MIN6 and can contribute to research and therapy aimed at diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84901428283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901428283&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2014.04.017

DO - 10.1016/j.biomaterials.2014.04.017

M3 - Article

C2 - 24816283

AN - SCOPUS:84901428283

VL - 35

SP - 6430

EP - 6438

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 24

ER -